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Abstract
Background: In rodents and pigs, it has shown that carnitine synthesis and uptake of carnitine into cells are
regulated by peroxisome proliferator-activated receptor a (PPARA), a transcription factor which is physiologically
activated during fasting or energy deprivation. Dairy cows are typically in a negative energy balance during early
lactation. We investigated the hypothesis that genes of carnitine synthesis and uptake in dairy cows are enhanced
during early lactation.
Results: mRNA abundances of PPARA and some of its classical target genes and genes involved in carnitine
biosynthesis [trimethyllysine dioxygenase (TMLHE), 4-N-trimethylaminobutyraldehyde dehydrogenase (ALDH9A1), g-
butyrobetaine dioxygenase (BBOX1)] and uptake of carnitine [novel organic cation transporter 2 (SLC22A5)] as well
as carnitine concentrations in liver biopsy samples of 20 dairy cows in late pregnancy (3 wk prepartum) and early
lactation (1 wk, 5 wk, 14 wk postpartum) were determined. From 3 wk prepartum to 1 wk postpartum, mRNA
abundances of PPARΑ and several PPARΑ target genes involved in fatty acid uptake, fatty acid oxidation and
ketogenesis in the liver were strongly increased. Simultaneously, mRNA abundances of enzymes of carnitine
synthesis (TMLHE: 10-fold; ALDH9A1: 6-fold; BBOX1: 1.8-fold) and carnitine uptake (SLC22A5: 13-fold) and the
concentration of carnitine in the liver were increased from 3 wk prepartum to 1 wk postpartum (P < 0.05). From 1
wk to 5 and 14 wk postpartum, mRNA abundances of these genes and hepatic carnitine concentrations were
declining (P < 0.05). There were moreover positive correlations between plasma concentrations of non-esterified
fatty acids (NEFA) and hepatic carnitine concentrations at 1 wk, 5 wk and 14 wk postpartum (P < 0.05).
Conclusions: The results of this study show for the first time that the expression of hepatic genes of carnitine
synthesis and cellular uptake of carnitine is enhanced in dairy cows during early lactation. These changes might
provide an explanation for increased hepatic carnitine concentrations observed in 1 wk postpartum and might be
regarded as a physiologic means to provide liver cells with sufficient carnitine required for transport of excessive
amounts of NEFA during a negative energy balance.
Background
Carnitine (3-hydroxy-4-N, N, N-trimethylaminobutyric
acid) is an essential metabolite that has a number of
indispensable functions in intermediary metabolism. The
most important function lies in its role in the transport
of activated long-chain fatty acids (acyl groups) from the
cytosol into the mitochondrial matrix where b-oxidation
takes place [1]. Carnitine is derived from dietary sources
and synthesized endogenously from trimethyllysine
(TML), which is released upon protein degradation. The
released TML is further oxidized to g-butyrobetaine
(BB) by the action of trimethyllysine dioxygenase
(TMLHE), 3-hydroxy-N-TML aldolase and 4-N-tri-
methylaminobutyraldehyde dehydrogenase (ALDH9A1).
In the final biosynthetic step, BB is hydroxylated by g-
butyrobetaine dioxygenase (BBOX1) to form carnitine.
In cattle this last step occurs only in liver and kidney
[2]. Tissues which are not capable of producing
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carnitine depend on the uptake of carnitine from blood
by novel organic cation transporters (OCTN), particu-
larly novel organic cation transporter 2 (SLC22A5)
which is the physiologically most important carnitine
transporter [3,4]. Studies in rodents and pigs demon-
strated that carnitine biosynthesis and uptake of carni-
tine from blood into cells by SLC22A5 are directly
regulated by peroxisome proliferator-activated receptor
a (PPARA), a transcription factor which plays a central
role in the adaptation of metabolism to energy defi-
ciency [5]. In these species, activation of PPARA such as
induced by fasting or treatment with synthetic agonists
led to increased tissue carnitine concentrations due to
an increased rate of biosynthesis and an increased
uptake of carnitine from blood into tissues [6-10].
In dairy cows, the transition from late pregnancy to
early lactation is associated with severe metabolic adap-
tations. Production of milk leads to a strong increase of
the energy requirement, which however cannot be met
as the food intake capacity is limited. Thus, during early
lactation, dairy cows are typically in a negative energy
balance which is compensated by the mobilization of
non-esterified fatty acids (NEFA) from adipose tissue.
NEFA are transported by binding with serum albumin
and are taken up by fatty acid transporters into tissues,
mainly the liver [11]. Studies in rodents have clearly
established that NEFA taken up into the liver are able
to bind to and activate PPARA [12,13]. In contrast to
the large body of literature in non-ruminants, very little
work has been conducted to define the specific effects
or mechanisms of PPARA in cattle liver so far. However,
a recent study using clofibrate as a synthetic agonist in
weaned calves showed that PPARA is functional in cat-
tle liver [14]. Moreover, it has been shown that long
chain fatty acids are able to activate PPARA also in
bovine cells [15]. In accordance with this finding, a
negative energy balance in dairy cattle, either occurring
physiologically during early lactation or induced by feed
restriction, was associated with an up-regulation of sev-
eral PPARA target genes involved in fatty acid oxidation
or ketosis in the liver, indicative of an activation of
PPARA [16,17].
To our knowledge, the regulation of carnitine home-
ostasis in dairy cattle has been less investigated. How-
ever, it has been found that hepatic carnitine
concentration in dairy cows is increasing during the
transition from late pregnancy to early lactation [18,19].
That finding and the assumption that genes involved in
carnitine homeostasis in dairy cows might be regulated
by PPARA such as in other species, prompted us to the
hypothesis that hepatic genes of carnitine synthesis and
uptake of carnitine are up-regulated during early lacta-
tion in dairy cows. To investigate this hypothesis, we
determined mRNA abundances of the relevant genes
involved in carnitine synthesis as well as carnitine con-
centrations in liver biopsy samples of dairy cows in late
pregnancy and early lactation.
Methods
The animal experiment was conducted at the Agricul-
tural Experimental Station Hirschau of the Technical
University of Munich, Germany. It was approved by the
Bavarian state animal care and use committee.
Animals and feeding
This study included twenty Holstein cows (four primi-
and sixteen multiparous, 2.7 ± 0.3 parities, mean ± SE)
as experimental animals with an experimental period
from 3 wk prepartum until 14 wk postpartum. The ani-
mals were housed in a playpen. Feeding was composed
of a partial mixed ration (PMR) for ad libitum intake of
basic feed and separately allocated concentrates [supple-
mental concentrate (SUPP), 0.63 kg DM/d for each cow;
individual concentrate (CONC), individual access]. PMR
consisted (dry matter, DM, basis) of 33.7% grass silage,
44.9% maize silage, 6.4% hay and 14.9% concentrate
while SUPP contained (DM basis) 24.4% soybean meal,
48.3% grain maize and 27.3% rumen-protected fat sup-
plement. With an assumed dry matter intake of 16 kg of
PMR/d and the alloted amount of SUPP, the calculated
nutrient supply covered the energy and protein require-
ments for 23 kg of milk/d. CONC was individually allo-
cated at four computer-operated feeding stations with
an automatic feeding program (DeLaval Alpro, Glinde,
Germany). CONC was composed of 24.8% grain maize,
21.8% wheat, 20.1% soybean meal, 15.2% dried sugar
beet pulp with molasses, 14.9% barley and 3.2% vitamin-
mineral premix including limestone (DM basis). The
allocation of CONC was increased from 1.2 to 8.0 kg of
DM/d during the first 42 d of lactation, and thereafter,
it was dependent on the milk performance of the indivi-
dual cow. Daily intakes of PMR and CONC were
recorded for each individual cow. The cows were gener-
ally in a good health condition, although four cows had
slight metabolic diseases (subclinical ketosis, subclinical
acidosis) and nine cows suffered temporarily from mas-
titis. All used feed components were sampled and ana-
lyzed for DM content, for crude nutrients, crude ash,
crude fibre and crude fat according to [20], and crude
protein by Dumas method. According to the German
Society of Nutrition Physiology [21], the net energy con-
tent (MJ NEL) and the available CP at the duodenum
were calculated. Nutrient concentrations and energy
content of all feed components are shown in Table 1.
Sample collection
Milking of lactating cows occured twice daily (0500 and
1500 h) in a 2 × 6 herringbone milking parlor (DeLaval).
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Milk yields of each cow were recorded automatically
and stored in data files. Representative milk samples (50
mL) from every individual cow comprised two consecu-
tive milking procedures (one evening and next morning
milking) and were collected twice weekly. Milk sampling
at 1, 5 and 14 wk postpartum occurred at days 5.1 ±
1.6, 29.7 ± 1.9, and 92.7 ± 1.9 (means ± SE), respec-
tively. At 3 wk prepartum (21.1 ± 6.0 d prepartum) and
1, 5 and 14 wk postpartum (3.7 ± 1.5, 30.9 ± 1.9 and
94.2 ± 2.6 d postpartum), blood samples of the dammed
vena jugularis were drawn using sterile 20 G canulas
and lithium heparin tubes (Greiner bio-one, Kremsmun-
ster, Austria). Blood sampling happened before morning
feeding between 0730 and 0900 h. Tubes were kept on
ice until subsequent centrifugation (2000 × g; 15 min).
Then, plasma was transferred into 1.5 mL tubes (Grei-
ner bio-one, Frickenhausen, Germany) and stored in ali-
quots at -20°C until analysis. Furthermore, liver biopsies
were taken at 3 wk prepartum (20.4 ± 5.8 d prepartum),
and 1, 5 and 14 wk postpartum (3.8 ± 1.4, 31.5 ± 2.1
and 94.9 ± 2.9 d postpartum). For this purpose, cows
were separated and fixed after morning milking before
feeding between 0700 and 0900 h. The liver biopsy site
on the right side of the cow between the 11th and 12th
ribs on a line between the olecranon and the tuber
coxae was shaved and disinfected before a local subcuta-
neous anesthesia with 5 mL Isocaine 2% (Procainhy-
drochloride/Epinephrin, Selectavet, Weyarn/Holzolling,
Germany) was performed. Then an autoclaved canula
was introduced as a duct for the sterile 14 G biopsy
needle (Dispomed Witt oHG, Gelnhausen, Germany)
and about 50 mg of liver tissue were removed and
immediately snap-frozen in liquid nitrogen. Samples
were stored at -80°C until further analysis. The biopsy
site was treated with wound spray and animals were
kept separated for one day.
Sample analysis
Milk protein and milk fat contents were analyzed by
infrared spectrophotometry (MilkoScan-FT-6000, Foss
Analytical A/S, Hillerod, Denmark) at the laboratory of
Milchprüfring Bayern e.V., Wolnzach, Germany. NEFA
and BHBA were determined in the thawed plasma
samples using commercial available kits [NEFA-HR(2)
and Autokit 3-HB, obtained from Wako Chemicals
GmbH, Neuss, Germany]. Lipids from liver biopsy sam-
ples were extracted with a mixture of n-hexane and iso-
propanol (3:2, vol/vol) [22]. An aliquot of the extracts
containing 25-50 nmoles of TAG was pipetted into a
glass vial (1.5 ml), and the solvent was evaporated by
vacuum. The lipids were resolved in a 20 μl portion of a
1:1-mixture of chloroform and Triton X-100 [23], and
again the solvent was evaporated. Then 1 ml of com-
mercially available enzymatic TAG kit reagent (Fluitest
TG, Analyticon Biotechnologies AG, Lichtenfels, Ger-
many) was added, and after incubation-according to the
instruction of the manufacturer-the TAG content was
determined by colorimetry.
Energy balance
For calculation of the average daily energy balance of
every individual cow, energy intake was calculated from
the mean daily intake of PMR, SUPP and CONC and
the corresponding energy contents (MJ NEL). Body
weights (BW) of the cows were automatically recorded
daily by electronic scales installed in the feeding sta-
tions. Using the weekly mean BW of the cows, energy
requirements for maintenance were calculated according
to the German Society of Nutrition Physiology [21].
Those for milk production were calculated on the basis
of weekly means of daily milk yield, milk protein con-
tent and milk fat content [21]. Changes in body compo-
sition were not considered in energy balance evaluation.
Carnitine analysis
Concentrations of total carnitine, free carnitine, acetyl-
carnitine and propionylcarnitine in plasma, milk and
liver tissue were determined by tandem mass spectro-
metry [24,25]. In brief, freeze dried tissue samples were
extracted with methanol:water (2:1 v/v) by homogeniza-
tion (Tissue Lyser, Qiagen, Hilden, Germany), followed
by sonification for 20 min and incubation at 50°C for 30
min in a shaker. After centrifugation (13000 × g, 10
min) 20 μL of the supernatant were added with 100 μL
methanol containing the internal standards, mixed, incu-
bated for 10 min, and centrifuged (13000 × g, 10 min).
Plasma and milk samples were handled at 4°C in the
same manner as the supernatant after tissue extraction.
The final supernatants were used for quantification of
the compounds by a 1100 series HPLC (Agilent Tech-
nologies, Waldbronn, Germany) equipped with a Kro-
masil 100 column (125 mm × 2 mm, 5 μm particle size,
CS-Chromatographie Service Langerwehe, Germany)
and an API 2000 LC-MS/MS-System (Applied Biosys-
tems, Darmstadt, Germany). As eluents, methanol and a
methanol:water:ACN:acetic acid mixture (100:90:9:1 v/v/
v/v) were used.
Table 1 Nutrient values of experimental feedstuff
PMR CONC SUPP
Energy* (MJ NEL/kg of DM) 6.45 8.00 12.8
Crude fibre (g/kg of DM) 214 67 69
Crude ash (g/kg of DM) 81 72 49
Crude fat (g/kg of DM) 32 20 303
CP (g/kg of DM) 129 184 140
Available CP (g/kg of DM)* 142 187 151
*calculated values
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RNA isolation and quantitative real-time PCR (qPCR)
Total RNA was isolated from liver biopsies using Trizol
reagent (Invitrogen, Karlsruhe, Germany) according to
the manufacturer’s protocol. RNA from 10 mg of each
sample was isolated within one week after finishing the
trial. Isolated RNA was preserved at -80°C until use. To
estimate RNA concentration and purity, the optical den-
sity at 260 and 280 nm, respectively, was determined
using an Infinite 200 M microplate reader and a Nano-
Quant Plate (both from Tecan, Mannedorf, Switzerland).
The A260/A280 ratios were 1.96 ± 0.05. In addition, the
optical density at 230 nm was determined and the
A260/A230 ratios were calculated to control for the pre-
sence of contaminations such as guanidine thiocyanate.
Although the A260/A230 ratio of some samples was
below 2.0 indicating the presence of guanidine thiocya-
nate, it has been shown that guanidine thiocyanate has
no measurable effect on downstream applications such
as RT-qPCR until concentrations of more than 100 mM
[26] Moreover, RNA quality was assessed by 1% agarose
gel electrophoresis. RNA was judged as suitable for only
if the samples exhibited intact bands corresponding to
the 18S and 28S ribosomal RNA subunits. cDNA was
synthesized after RNA extraction from 1.2 μg of total
RNA using 100 pmol dT18 primer (Eurofins MWG
Operon, Ebersberg, Germany), 1.25 μL 10 mmol/L
dNTP mix (GeneCraft, Ludinghausen, Germany), 5 μL
buffer (Fermentas, St. Leon-Rot, Deutschland), and 60
units M-MuLV Reverse Transcriptase (MBI Fermentas,
St. Leon-Rot, Germany) at 42°C for 60 min, and a final
inactivating step at 70°C for 10 min in Biometra Ther-
mal Cycler (Whatman BiometraR, Göttingen, Germany).
Subsequently, cDNA was stored in aliquots at -20°C.
For the standard curve a cDNA pool of all samples was
made. qPCR was performed using 2 μL cDNA combined
with 18 μL of a mixture composed of 10 μL KAPA
SYBR FAST qPCR Universal Mastermix (Peqlab, Erlan-
gen, Germany), 0.4 μL each of 10 μM forward and
reverse primers and 7.2 μL DNase/RNase free water in
0.1 mL tubes (Ltf Labortechnik, Wasserburg, Germany).
Gene-specific primer pairs obtained from Eurofins
MWG Operon (Ebersberg, Germany) were designed
using Primer3 and BLAST. Features of primer pairs are
listed in Table 2. All primer pairs were designed to have
annealing temperatures of about 60°C, and, if possible,
both primers of a primer pair were designed to be
located in different exons. qPCR runs were performed
with a Rotorgene 2000 system (Corbett Research, Mor-
tlake, Australia), and included all samples and a 5 point
relative standard curve plus the non-template control
(NTC). The qPCR protocol was as follows: 3 min at 95°
C, followed by 40 cycles of a two-step PCR consisting of
5 sec at 95°C (denaturation) and 20 sec at 60°C (anneal-
ing and extension). Subsequently, melting curve analysis
was performed from 50°C to 95°C to verify the presence
of a single PCR product. In addition, the amplification
of a single product of the expected size was confirmed
using 2% agarose gel electrophoresis stained with Gel-
RedTM nucleic acid gel stain (Biotium, California,
USA). Data on qPCR performance for each genes mea-
sured are also shown in Table 2. Reference gene stability
was determined by performing GeNorm analysis [27]
which is based on calculation of a reference gene-stabi-
lity measure M. Out of six tested potential reference
genes, the three reference genes with the lowest M
values have the most stable expression and are used to
calculate the GeNorm normalization factor. Therefore,
all Ct values were transformed into relative quantifica-
tion data by using the 2-ΔΔCt equation [28]. Using the
GeNorm normalization factor, relative expression levels
were calculated, and from normalized expression data,
means and SE were computed for samples of the same
lactation week. The mean of 3 wk prepartum was set to
1 and relative expression ratios of 1, 5 and 14 wk post-
partum are expressed as fold changes compared to 3 wk
prepartum.
Statistics
Data were statistically evaluated by a generalized linear
model, including the factors time point of sampling, ani-
mal, parity number and the interactions between these
factors, using the Minitab Statistical Software Release
13.0 (Minitab, State College, PA, USA). Prior to statisti-
cal analysis, all data were checked for normality and
outliers before statistical analysis. As there was no sig-
nificant effect of animal and parity number on the para-
meters investigated, only the effects of time point of
sampling are reported in the results section. Linear
regression models for relationships of carnitine concen-
trations in liver tissue with metabolic parameters at the
different time points were subjected to analysis by fitted
line plots. The significances of differences between the
groups over time were analyzed by Fisher’s multiple
range test. Differences were regarded as significant for P
< 0.05.
Results
Dry matter intake, performance and energy balance in
dairy cows in the transition period and at different stages
of lactation
Dry matter intake of the cows 1 wk postpartum was
similar to that 3 wk prepartum and increased thereafter
towards 5 and 14 wk postpartum (Table 3). The onset
of lactation led to a strong negative energy balance
(Table 3). Energy balance that was strongest negative in
1 wk postpartum was then improving. At 14 wk post-
partum, the cows returned to a slight positive energy
balance (Table 3). Milk yield was increasing from 1 to 5
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wk postpartum and was thereafter declining towards 14
wk postpartum (Table 3). Milk fat and milk protein con-
tents were highest at 1 wk postpartum and were there-
after declining (Table 3).
Relative mRNA abundances of PPARA and genes involved
in fatty acid uptake, fatty acid oxidation and ketogenesis
in the liver of dairy cows in the transition period and at
different stages of lactation
The relative mRNA abundance of PPARA in the liver
was increased from 3 wk prepartum to 1 wk postpartum
(P < 0.05) and was thereafter declining, reaching values
at 5 wk and 14 wk postpartum similar with that of 3 wk
prepartum (Figure 1). In accordance with the expression
pattern of PPARA, target genes involved in fatty acid
uptake (SLC27A1, CD36), mitochondrial and peroxiso-
mal b-oxidation (ACOX1, CPT1A, ACADM) and keto-
genesis (HMGCS2) were rising from 3 wk prepartum to
1 wk postpartum (P < 0.05, Figure 1). From 1 to 5 and
14 wk postpartum, mRNA abundances of these genes,
with the only exception of CD36, were declining (P <
0.05, Figure 1). mRNA abundances of ACOX1,
SLC27A1 and HMGCS2 remained at a higher level at 5
and 14 wk postpartum than at 3 wk prepartum (P <
Table 2 Characteristics and performance data of the primers used for reference gene-stability measure M and
quantitative real-time PCR analysis
Gene Forward primer (from 5’ to 3’) PCR product NCBI GenBank Slope R2 Efficiency M
Reverse primer (from 5’ to 3’)
Reference genes
ACTB ACTTGCGCAGAAAACGAGAT 120 AY141970 -0.30 0.99 1.99 0.039
CACCTTCACCGTTCCAGTTT
SDHA GCAGAACCTGATGCTTTGTG 185 NM_174178 -0.24 0.99 1.74 0.048
CGTAGGAGAGCGTGTGCTT
ATP5B GGACTCAGCCCTTCAGCGCC 229 NM_175796.2 -0.16 0.99 1.44 0.039
GCCTGGTCTCCCTGCCTTGC
RPS9 GTGAGGTCTGGAGGGTCAAA 108 BC148016 -0.31 0.99 2.04 0.040
GGGCATTACCTTCGAACAGA
PPIA GGCAAATGCTGGCCCCAACACA 87 NM_178320.2 -0.34 0.99 2.13 0.034
AGTACCACGTGCTTGCCATCCA
RPL12 CACCAGCCGCCTCCACCATG 84 NM_205797.1 -0.35 0.99 2.25 0.036
CGACTTCCCCACCGGTGCAC
Target genes
ACADM GCGAGTACCCTGTCCCATTA 243 NM_001075235 -0.29 0.99 1.93
CCTCAGTCATTCTCCCCAAA
ACOX1 CCATTGCCGTCCGATACAGT 99 BC102761 -0.27 0.96 1.88
GTTTATATTGCTGGGTTTGATAATCCA
ALDH9A1 CAGGATTCGGCAGAGAGAAC 229 NM_001046423 -0.28 0.99 1.90
TGAGCCATGAAGAGCATCAC
BBOX1 TCCAGCTGCCTACTCTGGAT 292 BC149884.1 -0.28 0.99 1.91
AGCTGAACCTTACCCCAGGT
CD36 GCATTCTGAAAGTGCGTTGA 179 BC103112 -0.28 0.98 1.91
CGGGTCTGATGAAAGTGGTT
CPT1A CAAAACCATGTTGTACAGCTTCCA 111 FJ415874 -0.32 0.99 2.09
GCTTCCTTCATCAGAGGCTTCA
HMGCS2 GCCCAATATGTGGACCAAAC 209 NM_001045883 -0.29 0.99 1.96
ATGGTCTCAGTGCCCACTTC
PPARA GGTGGAGAGTTTGGCAGAACCAGA 168 BT020756.1 -0.23 0.99 1.70
TCCCACTGCCCAGCTCCGATC
SLC22A5 CACAGTGGTCAGGAACATGG 181 BC105377 -0.28 0.99 1.89
AATGGTGTCTGGGAGTGGAG
SLC27A1 CTGAAGGAGACCTCCACAGC 208 NM_001033625.2 -0.30 0.99 1.99
GTGGTACAGGGGCAGACAGT
TMLHE TGGCAGGACACTGCTAGTTG 222 NM_001076064.1 -0.31 0.99 2.05
GACAGCCCGGTCATAGTTGT
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0.05, Figure 1). In contrast, mRNA abundances of
CPT1A and ACADM, two enzymes of mitochondrial b-
oxidation, returned to levels similar to those at 3 wk
prepartum (Figure 1).
Relative mRNA abundances of genes involved in carnitine
synthesis and carnitine uptake in the liver of dairy cows
in the transition period and at different stages of
lactation
mRNA abundances of the two genes involved in the for-
mation of g-butyrobetaine-the precursor of carnitine-
TMLHE and ALDH9A1, were strongly (10-, and 6-fold,
resp.) increased from 3 wk prepartum to 1 wk postpar-
tum (P < 0.05, Figure 2). mRNA abundance of BBOX1,
the enzyme which converts g-butyrobetaine into carni-
tine, was moderately (1.8-fold) increased from 3 wk pre-
partum to 1 wk postpartum (P < 0.05, Figure 2). mRNA
abundance of SLC22A5, the most important carnitine
transporter, was strongly (13-fold) increased from 3 wk
prepartum to 1 wk postpartum (P < 0.05, Figure 2).
With the exception of BBOX1, mRNA abundances of all
these genes involved in carnitine synthesis pathway and
carnitine uptake were declining from 1 wk to 5 and 14
wk postpartum. Nevertheless, mRNA abundances of
these genes in 5 and 14 wk postpartum remained at
levels higher than those at 3 wk prepartum (P < 0.05,
Figure 2).
Concentrations of carnitine in liver, plasma and milk of
dairy cows in the transition period and at different stages
of lactation
In the liver, free carnitine was nearly the exclusive form
of carnitine whereas concentrations of carnitine esters
(< 1 nmol/g) were only slightly above the detection limit
and are therefore not reported. Liver free carnitine con-
centration was rising from 3 wk prepartum to 1 wk
postpartum (P < 0.05) and was thereafter falling to levels
below those observed at 3 wk prepartum (Table 4). In
plasma, the concentration of free carnitine was strongly
decreasing from 3 wk prepartum to 1 wk postpartum
and was thereafter rising to values which remained how-
ever below those observed 3 wk prepartum (P < 0.05,
Table 4). In contrast, the concentration of carnitine
esters in plasma was increasing from 3 wk prepartum to
1 wk postpartum (P < 0.05) and was thereafter decreas-
ing; plasma concentration of carnitine esters at 14 wk
postpartum was even lower than that 3 wk prepartum
(P < 0.05, Table 4). Plasma concentration of total carni-
tine decreased from 3 wk prepartum to 1 wk postpar-
tum (P < 0.05) and remained thereafter at a constant
level (Table 4). Concentrations of free, esterified and
total carnitine in milk were highest at 1 wk postpartum;
concentrations were thereafter decreasing and were
similar at 5 wk and 14 wk postpartum (Table 4).
Correlations between liver carnitine concentration and
phenotypic measures (plasma NEFA and BHBA, hepatic
concentration of TAG)
In order to assess whether plasma NEFA concentrations
influence liver carnitine concentrations, we calculated a
linear regression between plasma NEFA and liver carni-
tine concentrations. As expected, plasma NEFA concen-
trations were strongly increasing from 3 wk prepartum
to 1 wk postpartum and were thereafter declining
(Table 5). At all the three time points considered during
lactation (1 wk, 5 wk, 14 wk postpartum), a significant
positive correlation between plasma NEFA concentra-
tion and liver carnitine concentration was observed (P <
0.05, Table 6). In contrast, an inverse correlation
between plasma NEFA concentration and liver carnitine
concentration was observed at 3 wk prepartum. In order
to elucidate whether liver carnitine status influences
hepatic TAG accumulation or ketone body formation,
we calculated linear regressions between liver carnitine
concentrations and liver TAG concentrations or plasma
BHBA concentrations. As expected, liver TAG
Table 3 Performance of dairy cows in the transition period and at different stages of lactation
Variable 3 wk
prepartum
1 wk
postpartum
5 wk
postpartum
14 wk
postpartum
wks 1 to 14
postpartum
P-
value
Dry matter intake (kg/d) 13.4c ± 0.33 13.4c ± 0.48 18.4b ± 0.62 20.4a ± 0.53 18.5 ± 0.49 < 0.001
Milk yield (kg/d) - 28.6c ± 0.76 37.5a ± 0.90 32.0b ± 0.81 32.7 ± 0.67 < 0.001
FCM* (kg/d) - 39.2a ± 1.39 40.9a ± 1.51 33.0b ± 1.03 37.7 ± 0.87 < 0.001
Milk fat (%) - 6.40a ± 0.25 4.51b ± 0.20 4.11b ± 0.13 5.00 ± 0.17 < 0.001
Milk protein (%) - 4.09a ± 0.09 2.85c ± 0.05 3.13b ± 0.06 3.35 ± 0.08 < 0.001
Energy balance† (MJ NEL/d) 46.9a ± 2.42 -64.9d ± 5.15 -30.4c ± 3.05 3.89b ± 2.11 -12.5 ± 5.52 < 0.001
Energy intake† (% of
requirement)
215.1 ± 7.92 58.9 ± 2.45 82.3 ± 2.22 102.1 ± 2.10 81.1 ± 2.63 < 0.001
Values are mean ± SE (n = 20)
a, b, c, d Means with different superscripts differ significantly (P < 0.05)
* Corrected for 4% milk fat content
† Calculated value
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Figure 1 Relative mRNA abundances of PPARA and genes involved in fatty acid uptake, fatty acid oxidation and ketogenesis. Relative
mRNA abundances of PPARA and genes involved in fatty acid uptake (SLC27A1, CD36), fatty acid oxidation (ACOX1, CPT1A, ACADM) and
ketogenesis (HMGCS2) in the liver of dairy cows in the transition period and at different stages of lactation; bars represent means ± SE (n = 20)
and are expressed relative to the mRNA abundance at 3 wk prepartum. a, b, c Bars with different superscripts differ significantly (P < 0.05).
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Figure 2 Relative mRNA abundances of genes involved in carnitine synthesis and carnitine uptake. Relative mRNA abundances of genes
involved in carnitine synthesis (TMLHE, ALDH9A1, BBOX1) and carnitine uptake (SLC22A5) in the liver of dairy cows in the transition period and
at different stages of lactation; bars represent means ± SE (n = 20) and are expressed relative to the mRNA abundance at 3 wk prepartum. a, b, c
Bars with different superscripts differ significantly (P < 0.05).
Table 4 Concentrations of carnitine in liver biopsy, plasma and milk samples of dairy cows in the transition period
and at different stages of lactation
3 wk prepartum 1 wk postpartum 5 wk postpartum 14 wk postpartum P-value
Liver tissue
free carnitine, nmol/g wet weight 37.4b ± 4.53 55.6a ± 4.09 26.0c ± 1.76 18.2c ± 1.26 < 0.001
Plasma
free carnitine, μmol/L 3.82a ± 0.25 1.40c ± 0.10 2.18b ± 0.20 2.35b ± 0.17 < 0.001
carnitine esters*, μmol/L 2.07b ± 0.10 2.54a ± 0.12 2.45ab ± 0.18 1.64c ± 0.11 < 0.001
total carnitine†, μmol/L 5.89a ± 0.33 3.94b ± 0.17 4.64b ± 0.32 3.99b ± 0.26 < 0.001
Milk
free carnitine, μmol/L - 84.5a ± 5.92 50.3b ± 4.34 60.2b ± 2.65 < 0.001
carnitine esters*, μmol/L - 131.1a ± 12.1 65.9b ± 6.23 41.3c ± 2.60 < 0.001
total carnitine†, μmol/L - 215.5a ± 16.6 116.2b ± 7.92 101.5b ± 3.93 < 0.001
Values are mean ± SE (n = 20)
a, b, c Means with different superscripts differ significantly (P < 0.05)
*Sum of acetyl- and propionyl carnitine, †Sum of free carnitine and carnitine esters
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concentration was highest at 5 wk postpartum and
BHBA concentrations were highest at 1 wk and 5 wk
postpartum (Table 5). However, no significant correla-
tions between liver carnitine concentrations and liver
TAG or plasma BHBA concentrations emerged, both
pre- and postpartum (Table 6).
Discussion
This study was performed to investigate the hypothesis
that the onset of lactation in dairy cows leads to an up-
regulation of genes involved in hepatic carnitine synth-
esis and uptake of carnitine. As expected, the transition
from late pregnancy to early lactation was associated
with a strong negative energy balance resulting in
increased concentrations of NEFA and BHBA in plasma
and an increase in hepatic TAG concentration. Similar
metabolic changes during the periparturient period in
cows have been observed in many other studies [e.g.
[16,18,29]]. In agreement with a recent study [16], we
observed that the negative energy balance occurring at
early lactation was associated with an increased expres-
sion of several PPARA target genes involved in fatty
acid uptake, mitochondrial and peroxisomal fatty acid
oxidation and ketogenesis. Although we were not able
to give direct proof of PPARA activation due to small
liver sample amount available, an up-regulation of var-
ious PPARA target genes is indicative of an activation of
that transcription factor in the liver. While there is less
research about activation of PPARA in cattle, studies in
other species such as rodents or pigs have clearly shown
that increased plasma NEFA concentrations, induced by
energy deprivation, are leading to an activation of
PPARA in liver and other tissues [12,13,30]. As long-
chain fatty acids are also acting as agonists of PPARA in
bovine cells [15], it seems justified to speculate that high
plasma NEFA concentrations in dairy cows during early
lactation were causing an activation of PPARA in the
liver. It should be noted, however, that in opposite to
our study and the study of Loor et al. [16], there are
also studies which did not observe an up-regulation of
PPARA and PPARA target genes in the liver of dairy
cattle during early lactation, particularly when cows had
prepartum a caloric intake in excess of 100% of their
energy requirement [31,32]. The lack of up-regulation of
PPARA during early lactation in these studies has been
explained by a hepatic inflammatory response, induced
by an excessive prepartum caloric intake, which
decreased pre- and postpartum hepatic expression of
expression of PPARA [32].
In accordance with the hypothesis of this study, we
observed for the first time that the transition from late
pregnancy to early lactation leads to an up-regulation of
various genes involved in carnitine synthesis
(ALDH9A1, TMLHE, BBOX1) and carnitine uptake
(SLC22A5) in the liver of cows at 1 wk postpartum. As
all these genes are PPARA target genes with functional
PPREs identified in their promoters or first introns
[32-35], we assume that the up-regulation of these genes
in the liver of dairy cows at 1 wk postpartum was
caused by a potential activation of PPARA. The finding
of positive correlations between plasma concentrations
of NEFA, which might be regarded as natural agonists,
and hepatic carnitine concentrations during lactation
supports a role of PPARA in the regulation of genes of
carnitine synthesis and uptake.
The present study confirms previous studies in show-
ing that liver carnitine concentration is increasing dur-
ing the transition from late pregnancy to lactation and
is thereafter continuously decreasing to values similar or
even below those observed in pregnancy [18,19]. In the
study of Carlson et al. [19], hepatic total carnitine con-
centrations were around 1.6-fold higher on 2 d of lacta-
tion compared to 3 wk prepartum, while values at d 28
were even lower than those 3 wk prepartum. In the
study of Grum et al. [18], concentrations of acid-soluble
carnitine (free carnitine plus short-chain acyl carnitine)
sharply increased from 3 wk prepartum to 1 d postpar-
tum and returned to prepartum values at d 21 postpar-
tum. As carnitine is synthesized from trimethyllysine
released primarily from turnover of skeletal muscle pro-
teins, Grum et al. [18] suggested that an increased hepa-
tic carnitine concentration at 1 d postpartum might be
due to an enhanced catabolism of muscle protein in this
early stage of lactation. Although we have not directly
measured carnitine synthesis and uptake into cells, the
findings of increased mRNA expression of genes of car-
nitine synthesis and uptake suggest that increased hepa-
tic carnitine concentrations at early lactation could also
Table 5 Metabolic parameters in liver biopsy and plasma samples of dairy cows in the transition period and at
different stages of lactation
3 wk prepartum 1 wk postpartum 5 wk postpartum 14 wk postpartum P-value
Plasma NEFA (μmol/L) 103d ± 10 864a ± 47 276b ± 16 171c ± 11 < 0.001
Liver triglyceride (mg/g wet weight) 4.56c ± 0.45 23.5b ± 2.6 64.3a ± 10.3 3.18c ± 0.28 < 0.001
Plasma BHBA (μmol/L) 484b ± 23 707a ± 42 724a ± 46 521b ± 24 < 0.001
Values are mean ± SE (n = 20).
a, b, c, d Means with different superscripts differ significantly (P < 0.05)
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be due, at least in part, to an increased carnitine synth-
esis in the liver and an increased uptake of carnitine
from blood into the liver. This suggestion is supported
by studies in rodents and pigs which found that an up-
regulation of enzymes of carnitine synthesis in the liver,
caused either by treatment with PPARA agonists or by
energy deprivation, leads to an increased hepatic carni-
tine concentration without changing the concentrations
of BB or TML, the precursors of carnitine synthesis
[7,8,36,37]. The finding that the concentration of free
carnitine in plasma is strongly decreasing from 3 wk
prepartum to 1 wk postpartum fits into this suggestion.
Studies in rodents have shown that an up-regulation of
SLC22A5 by treatment with PPARA agonists or by
energy deprivation leads to a reduction of plasma carni-
tine concentration, due to an increased transport of car-
nitine from plasma into tissues [6,8,36]. The decrease in
plasma carnitine concentrations during early lactation
might be in part explained by the transfer of carnitine
from plasma into the milk in mammary gland. Never-
theless, with respect to the findings in rodents, we
assume that reduced plasma carnitine concentrations in
early lactation could also be caused by an increased
uptake of free carnitine from plasma into tissues, includ-
ing the liver. In accordance with present study, Carlson
et al. [19] also observed a strong reduction of plasma
carnitine concentration from 21 d prepartum to 9 or 27
d postpartum. Those authors [19] also found that carni-
tine concentration in skeletal muscle is not changing
significantly during transition from pregnancy into lacta-
tion. This finding also agrees with studies in rodents
which show that energy deprivation does not influence
muscle carnitine concentrations [7,36].
Furthermore, we observed that milk carnitine concen-
tration is highest at 1 wk postpartum and is thereafter
decreasing to 5 wk and 14 wk postpartum. This finding
agrees with the study of Carlson et al. [19] which found
a strong reduction of milk carnitine concentration from
2 wk to 6 wk postpartum. It is possible that the high
carnitine concentration in milk at wk 1 postpartum is
due to the strong negative energy balance of the cows.
Carlson et al. [38] found that energy restriction of cows
increased milk carnitine concentrations. In the mam-
mary gland, carnitine is secreted into the milk by several
transporters (SLC22A4, SLC22A5, OCTN3, SLC6A14,
SLC6A10) [39]. Possibly, one or more of these transpor-
ters are up-regulated in a state of a negative energy bal-
ance. Studies in rats also found a reduction of milk
carnitine concentration from early to later stage of lacta-
tion, due to a down-regulation of SLC22A5, OCTN3
and SLC6A14 [39].
Ketosis and fatty liver are two diseases in dairy cows
during early lactation which are linked to hepatic fatty
acid oxidation [40]. As carnitine is involved in b-oxida-
tion due to its role in the transport of long chain fatty
acids into the mitochondrion, it was interesting to
explore whether plasma ketone body concentrations or
hepatic TAG concentrations are correlated with hepatic
carnitine concentrations. The observation that there
were no correlations between hepatic carnitine concen-
tration and both, plasma BHBA and hepatic TAG con-
centrations, at 1, 5 and 14 wk postpartum suggests that
the availability of carnitine in the liver had no influence
on ketogenesis and TAG accumulation in the liver. The
observation that hepatic carnitine concentration does
not correlate with BHBA concentration is in accordance
with a study showing that carnitine supplementation
does not influence plasma BHBA concentration in early
lactating dairy cattle [41]. The finding that the activity
of CPT1A does not play a primary role in the etiology
of ketosis [42] is another indication that the availability
of carnitine, which acts as a cofactor of that enzyme, is
Table 6 Linear regression parameters for the relationship of concentration of free carnitine in liver biopsy samples
(nmol/g wet weight) as predictor variable with different metabolic parameters of dairy cows in the transition period
and at different stages of lactation as response variables
Response variable 3 wk prepartum 1 wk postpartum 5 wk postpartum 14 wk postpartum
Plasma NEFA (μmol/L) Intercept 152.7 285.7 115.7 81.4
Slope -1.17 10.2 5.86 4.66
R2 0.29 0.64 0.38 0.26
P-value 0.015 < 0.001 0.008 0.035
Liver triglyceride (mg/g wet weight) Intercept 3.07 30.5 44.1 3.81
Slope 0.04 -0.14 0.65 -0.05
R2 0.15 0.09 0.01 0.09
P-value 0.112 0.291 0.673 0.305
Plasma BHBA (μmol/L) Intercept 562.8 605.3 603.7 503.3
Slope -1.84 1.43 4.56 0.60
R2 0.13 0.02 0.03 0.00
P-value 0.113 0.621 0.505 0.907
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not a key factor in the production of ketone bodies.
Accumulation of TAG in the liver is explained by the
observation that the capacity of bovine liver tissue to
convert fatty acids to esterified products is strongly
increased during the early postnatal period, whereas
fatty acid oxidation is only slightly increased, meaning
that NEFA from mobilization are directed towards con-
version to TAG [43]. The finding that there was no cor-
relation between hepatic carnitine concentration and
hepatic TAG concentration thus indicates that a higher
hepatic carnitine concentration did not stimulate hepatic
fatty acid oxidation. This indication is, however, in con-
tradiction to some in vitro and in vivo studies in dairy
cows. In vitro studies using bovine liver slices have
shown that addition of carnitine enhances the oxidation
of palmitate [44,45]. Moreover, postruminal infusion of
carnitine enhanced palmitate oxidation and decreased
liver lipid accumulation in cows with experimentally
induced negative energy balance [41]. These studies sug-
gested that carnitine might be the rate-limiting factor of
hepatic b-oxidation in dairy cows during the periparturi-
ent period and that carnitine supplementation might
prevent the development of a fatty liver.
Conclusions
The present study shows for the first time that hepatic
mRNA abundances of genes involved in carnitine synth-
esis and cellular uptake of carnitine in dairy cows are
increased during the transition from late pregnancy to
lactation. An up-regulation of genes involved in carni-
tine biosynthesis and uptake could contribute to ele-
vated hepatic carnitine concentration in early lactation
observed in this and previous studies.
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